• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮中心血管事件的荟萃分析。

A Meta-Analysis of Cardiovascular Events in Systemic Lupus Erythematosus.

机构信息

a Department of Epidemiology and Health Statistics , School of Public Health, Anhui Medical University , Hefei , Anhui , China.

b Anhui Province Key Laboratory of Major Autoimmune Disease, Anhui Medical University , Hefei , Anhui , China.

出版信息

Immunol Invest. 2019 Jul;48(5):505-520. doi: 10.1080/08820139.2019.1567534. Epub 2019 Apr 8.

DOI:10.1080/08820139.2019.1567534
PMID:30961407
Abstract

: To identify accurate occurrence and risk of cardiovascular (CV) events (stroke and myocardial infarction [MI]) in patients with systemic lupus erythematosus (SLE). : Systemic literature search in PubMed and additional manual search were performed to obtain interested studies until March 31, 2018. The pooled incidences and risk of stroke and MI were calculated. : A total of 24 studies were included in this meta-analysis. For MI, a total of 1,516 SLE patients were reported to had MI (n = 96,154) over a mean follow-up of 9.98 years: incidence 2.0% (95% CI: 1.7-2.4%), i.e. 0.20/100 pyrs; in the five studies, 360 SLE patients (n = 18,943) and 817 controls had MI (n = 111,525), revealing that the risk of MI in SLE population was 3.04 times higher than in the general population (RR = 3.04, 95% CI: 1.81-5.11). For stroke, the incidence of 17 studies during the 10.09 follow-up period using random model was 4.4% (95% CI: 3.6-5.1%), i.e. 0.44/100 pyrs; in the 7 studies, 694 SLE patients (n = 22,594) and 4,034 controls had stroke (n = 255,023), indicating that the risk of MI in SLE population was 1.95 times higher than that in the general population (RR = 1.95, 95% CI: 1.52-2.53). : Based on the findings from previous reports, our meta-analysis showed that patients with SLE have been at higher risk of CV events.

摘要

: 目的:明确系统性红斑狼疮(SLE)患者发生心血管(CV)事件(中风和心肌梗死[MI])的准确发生率和风险。 : 对 PubMed 中的系统文献进行检索,并进行额外的手动搜索,以获取截至 2018 年 3 月 31 日的相关研究。计算中风和 MI 的合并发生率和风险。 : 共有 24 项研究纳入本荟萃分析。对于 MI,共有 1516 例 SLE 患者报告在平均 9.98 年的随访中有 MI(n=96154):发生率为 2.0%(95%CI:1.7-2.4%),即 0.20/100 人年;在五项研究中,360 例 SLE 患者(n=18943)和 817 名对照者发生了 MI(n=111525),表明 SLE 人群的 MI 风险比一般人群高 3.04 倍(RR=3.04,95%CI:1.81-5.11)。对于中风,采用随机模型的 17 项研究在 10.09 年的随访期间的发生率为 4.4%(95%CI:3.6-5.1%),即 0.44/100 人年;在 7 项研究中,694 例 SLE 患者(n=22594)和 4034 名对照者发生了中风(n=255023),表明 SLE 人群的中风风险比一般人群高 1.95 倍(RR=1.95,95%CI:1.52-2.53)。 : 基于之前报告的结果,我们的荟萃分析表明,SLE 患者发生 CV 事件的风险较高。

相似文献

1
A Meta-Analysis of Cardiovascular Events in Systemic Lupus Erythematosus.系统性红斑狼疮中心血管事件的荟萃分析。
Immunol Invest. 2019 Jul;48(5):505-520. doi: 10.1080/08820139.2019.1567534. Epub 2019 Apr 8.
2
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis.系统性红斑狼疮患者的心血管事件和风险:系统文献回顾和荟萃分析。
Lupus. 2023 Mar;32(3):325-341. doi: 10.1177/09612033221147471. Epub 2022 Dec 22.
3
Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis.系统性红斑狼疮;中风和心肌梗死风险:一项系统评价和荟萃分析
RMD Open. 2020 Sep;6(2). doi: 10.1136/rmdopen-2020-001247.
4
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.新诊断系统性红斑狼疮患者心肌梗死和中风的风险:一项基于人群的研究
Arthritis Care Res (Hoboken). 2017 Jun;69(6):849-856. doi: 10.1002/acr.23018. Epub 2017 May 9.
5
Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.系统性红斑狼疮患者的心血管事件:瑞典北部的 7 年随访研究中的发生率和预测因素。
Lupus. 2012 Apr;21(4):452-9. doi: 10.1177/0961203311425524. Epub 2011 Nov 7.
6
The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study.系统性红斑狼疮和狼疮性肾炎中心血管疾病发病率及心血管疾病死亡率的风险:一项基于丹麦全国人口的队列研究。
Rheumatology (Oxford). 2017 May 1;56(5):709-715. doi: 10.1093/rheumatology/kew475.
7
Hydroxychloroquine and Cardiovascular Events in Patients With Systemic Lupus Erythematosus.羟氯喹与系统性红斑狼疮患者的心血管事件。
JAMA Netw Open. 2024 Aug 1;7(8):e2432190. doi: 10.1001/jamanetworkopen.2024.32190.
8
Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: A systematic review and Meta-analysis.系统性红斑狼疮患者面临较高的心血管疾病风险:系统评价和荟萃分析。
Int Immunopharmacol. 2021 May;94:107466. doi: 10.1016/j.intimp.2021.107466. Epub 2021 Feb 23.
9
Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.系统性红斑狼疮(SLE)患者心血管事件的预测因素:一项系统评价和荟萃分析
Eur J Prev Cardiol. 2015 Nov;22(11):1435-41. doi: 10.1177/2047487314546826. Epub 2014 Aug 19.
10
Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.种族/民族与系统性红斑狼疮患者的心血管事件。
Arthritis Rheumatol. 2017 Sep;69(9):1823-1831. doi: 10.1002/art.40174. Epub 2017 Aug 13.

引用本文的文献

1
Enhancing predictions of subclinical cardiac dysfunction in SLE patients through integrative machine learning analysis.通过综合机器学习分析提高系统性红斑狼疮患者亚临床心脏功能障碍的预测能力。
Lupus Sci Med. 2025 Sep 1;12(2):e001616. doi: 10.1136/lupus-2025-001616.
2
Atherosclerotic Plaque Progression and Incident Cardiovascular Events in a 10-Year Prospective Study of Patients With Systemic Lupus Erythematosus: The Impact of Persistent Cardiovascular Risk Factor Target Attainment and Sustained DORIS Remission.一项针对系统性红斑狼疮患者的10年前瞻性研究中的动脉粥样硬化斑块进展与心血管事件发生率:持续达到心血管危险因素目标及持续疾病缓解状态的多中心狼疮国际协作研究(DORIS)缓解的影响
Arthritis Rheumatol. 2025 Jun;77(6):716-726. doi: 10.1002/art.43097. Epub 2025 Jan 24.
3
Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus.系统性红斑狼疮中风的发病机制、预防策略、管理方案、药物治疗及研究技术解析
Medicines (Basel). 2024 Jul 31;11(7):15. doi: 10.3390/medicines11070015.
4
Unique Metabolomic and Lipidomic Profile in Serum From Patients With Crohn's Disease and Ulcerative Colitis Compared With Healthy Control Individuals.与健康对照个体相比,克罗恩病和溃疡性结肠炎患者血清中独特的代谢组学和脂质组学特征。
Inflamm Bowel Dis. 2024 Dec 5;30(12):2405-2417. doi: 10.1093/ibd/izad298.
5
Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the of the issue.炎症性肠病中的动脉粥样硬化性心血管疾病:深入探讨该问题。 (你提供的原文“to the of the issue”表述不完整,可能影响准确理解,以上译文是基于推测尽量完善后的内容)
Front Cardiovasc Med. 2023 May 16;10:1143293. doi: 10.3389/fcvm.2023.1143293. eCollection 2023.
6
Clinical characterization of a cohort of patients treated for systemic lupus erythematosus in Colombia: A retrospective study.对在哥伦比亚接受系统性红斑狼疮治疗的患者队列进行的临床特征描述:一项回顾性研究。
PLoS One. 2023 May 18;18(5):e0285889. doi: 10.1371/journal.pone.0285889. eCollection 2023.
7
Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: an umbrella review.系统性红斑狼疮患者心血管疾病的风险因素:伞式综述。
Clin Rheumatol. 2023 Nov;42(11):2931-2941. doi: 10.1007/s10067-023-06608-6. Epub 2023 May 5.
8
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis.系统性红斑狼疮患者的心血管事件和风险:系统文献回顾和荟萃分析。
Lupus. 2023 Mar;32(3):325-341. doi: 10.1177/09612033221147471. Epub 2022 Dec 22.
9
An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management.系统性红斑狼疮(SLE)的发病机制、分类及管理概述
Cureus. 2022 Oct 15;14(10):e30330. doi: 10.7759/cureus.30330. eCollection 2022 Oct.
10
More than skin deep: Recognizing cardiovascular co-morbidities in medical dermatology. A Fellow's Voice.不止于皮肤表面:认识医学皮肤科中的心血管合并症。一位研究员的观点。
Am J Prev Cardiol. 2022 Aug 18;11:100374. doi: 10.1016/j.ajpc.2022.100374. eCollection 2022 Sep.